The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped i

admin2014-10-21  50

问题 The pharmaceutical industry argues that because new drugs will not be developed unless heavy development costs can be recouped in later sales, the current 20 years of protection provided by patents should be extended in the case of newly developed drugs. However, in other industries new-product development continues despite high development costs, a fact that indicates that the extension is unnecessary. Which of the following, if true, most strongly supports the pharmaceutical industry s argument against the challenge made above?

选项 A、No industries other than the pharmaceutical industry have asked for an extension of the 20-year limit on patent protection.
B、Clinical trials of new drugs, which occur after the patent is granted and before the new drug can be marketed, often now take as long as 10 years to complete.
C、There are several industries in which the ratio of research and development costs to revenues is higher than it is in the pharmaceutical industry.
D、An existing patent for a drug does not legally prevent pharmaceutical companies from bringing to market alternative drugs, provided they are sufficiently dissimilar to the patented drug.
E、Much recent industrial innovation has occurred in products—for example, in the computer and electronics industries—for which patent protection is often very ineffective.

答案B

解析 本题让我们支持一方驳斥另一方,应利用双方的争论焦点来定位选项。很明显,段落的质疑与医药行业的论点之争主要在于有无必要延长专利权保护年限,因此答案应与时间有关。若新药品的临床试验需要10年时间完成,且试验是在专利权授予之后与新药品上市获得收入以前,如(B)所说,那么对巨额开发费用的补偿只有10年时间,补偿的时间变得更短了,因此需要延长专利时间,所以支持了医药行业观点而反对了上述质疑。(D)易误选,但(D)与时间无关;(A)、(E)都是无关选项;(C)为一无关比较。
转载请注明原文地址:https://kaotiyun.com/show/gqtO777K
本试题收录于: GMAT VERBAL题库GMAT分类
0

最新回复(0)